Cargando…

Post-vaccinal minimal change disease

Detalles Bibliográficos
Autores principales:	Weijers, Jari, Alvarez, Carmen, Hermans, Marc M.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191283/ https://www.ncbi.nlm.nih.gov/pubmed/34119510 http://dx.doi.org/10.1016/j.kint.2021.06.004

Ejemplares similares

Minimal change disease following vaccination with CoronaVac
por: Dirim, Ahmet Burak, et al.
Publicado: (2021)

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
por: Morlidge, Clare, et al.
Publicado: (2021)

Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination
por: Leong, Leanne Ca-Yin, et al.
Publicado: (2021)

Minimal Change Disease Associated With Durvalumab
por: Toda, Masataro G., et al.
Publicado: (2021)

Kimura Disease Associated with Minimal Change Disease
por: Eren, Rafet, et al.
Publicado: (2021)

Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
por: Tanaka, Fumika, et al.
Publicado: (2021)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome in minimal change disease
por: Swarnalatha, G., et al.
Publicado: (2012)

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
por: D’Agati, Vivette D., et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
por: Schwotzer, Nora, et al.
Publicado: (2021)

Over-immunosuppression can be life threatening in minimal change disease
por: Bakul, G., et al.
Publicado: (2014)

Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination
por: Jongvilaikasem, Pondtip, et al.
Publicado: (2022)

Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report
por: Özkan, Gülsüm, et al.
Publicado: (2021)

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine
por: Salem, Fadi, et al.
Publicado: (2021)

The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Milford, D V
Publicado: (1997)

Free fatty acids, glucose, and insulin in type 2 diabetes mellitus
por: Weijers, Rob NM
Publicado: (2022)

Optimal allocation of limited vaccine to minimize the effective reproduction number()
por: Rao, Isabelle J., et al.
Publicado: (2021)

Isolated abducens nerve palsy following Covid-19 vaccine
por: Khalili, M.R., et al.
Publicado: (2022)

Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
por: Fischer, Suzanne, et al.
Publicado: (2023)

CD44 staining in parietal epithelial cells and early steroid response in patients with minimal change disease
por: Morel, Antoine, et al.
Publicado: (2023)

Post-SARS-CoV-2 Vaccine Monitoring of Disease Flares in Autoinflammatory Diseases
por: Alehashemi, Sara, et al.
Publicado: (2022)

Infectious disease scenarios in a post-vaccine view of COVID-19 and future pandemics
por: Cola, João Paulo, et al.
Publicado: (2021)

Detecting post-surgical recurrence in a patient with Cushing’s disease
por: Moloney, Kelley J., et al.
Publicado: (2014)

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia
por: Bassan, R, et al.
Publicado: (2014)

Robotic pyeloplasty in an infant: Minimal access surgery with minimal ‘access’ to the patient
por: Dhar, Mridul, et al.
Publicado: (2019)

Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestation
por: Putri, Denise Utami, et al.
Publicado: (2023)

Henoch-Schönlein purpura presenting post COVID-19 vaccination
por: Hines, Adam M., et al.
Publicado: (2021)

Post COVID-19 Vaccination GBS—Association or Causation?
por: Jain, Rajendra S., et al.
Publicado: (2022)

COVID-19, Vaccination, Multisystem Inflammatory Syndrome, Aneurysm, Screening and Post Vaccination Death
por: Joob, Beuy, et al.
Publicado: (2023)

Minimally Invasive Percutaneous Techniques for the Relief of Pain in Lumbar Disc Disease
por: Sinan, Tariq, et al.
Publicado: (2011)

Post RNA-based COVID vaccines myocarditis: Proposed mechanisms
por: Kadkhoda, Kamran
Publicado: (2022)

Management of COVID-19 post-vaccine Bell's palsy in an outpatient
por: Cellina, Michaela, et al.
Publicado: (2022)

One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Maximum aesthetics with minimal intervention
por: Koirala, Sushil
Publicado: (2010)

Integrated infection control strategy to minimize nosocomial infection of coronavirus disease 2019 among ENT healthcare workers
por: Lu, D., et al.
Publicado: (2020)

Noninvasive mechanical ventilation and COVID-19. Minimizing dispersion()
por: Hernández Garcés, H., et al.
Publicado: (2020)

Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children
por: Levy, Corinne, et al.
Publicado: (2021)

Post-SARS-CoV-2 vaccination thrombosis is frequent and ubiquitous
por: Finsterer, Josef
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7fmb50k2f3jp8g4et17f6el9o1